BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3274385)

  • 1. Release of interleukins during tolerance and rejection of human renal allografts.
    Charpentier B; Lantz O; Lang P; Martin B; Fries D
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1572-3. PubMed ID: 3274385
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine inhibits nonspecific transfusion-induced immunity in dogs.
    Kyriakides GK; Esquenazi V; Olson L; Milgrom M; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1432-3. PubMed ID: 2978877
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional analysis of infiltrating cells from rat renal allografts during ongoing rejection.
    Hamashima T; Yoshimura N; Kita M; Oka T
    Transplant Proc; 1989 Apr; 21(2):3264-5. PubMed ID: 2496502
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic mechanisms inducing tolerance to allografts].
    Martorell J
    Nefrologia; 2004; 24 Suppl 4():67-71. PubMed ID: 15279390
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensitization following donor-specific transfusions detected by 51Cr release assays--CyA modulation of early rejection effects.
    Birtch AG; McConnachie P; Lewis WI
    Transplant Proc; 1987 Feb; 19(1 Pt 1):805-7. PubMed ID: 3079166
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of in vivo cyclosporine on interleukin production in kidney transplant recipients.
    Yoshimura N; Oka T; Ohmori Y; Aikawa I; Fukuda M; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1194-8. PubMed ID: 3547855
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of renal allografts by simultaneous cyclosporine and donor-specific blood transfusion.
    Francis DM; Masendycz PJ; Dumble LJ; Clunie GJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1464-6. PubMed ID: 3274356
    [No Abstract]   [Full Text] [Related]  

  • 8. Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance.
    Taube D; Welsh KI; Bewick M; Dische FE; Palmer A; Parsons V; Snowden S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1961-3. PubMed ID: 3274456
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?
    Abbud-Filho M; Kupiec-Weglinski JW; Araujo JL; Heidecke CD; Tilney NL; Strom TB
    J Immunol; 1984 Nov; 133(5):2582-6. PubMed ID: 6237152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytotoxic antibodies in 1500 potential first kidney transplant recipients.
    Lieber SR; Gerbase-DeLima M; Persoli LB; Pedro-Filho F; Setta JH; Montagna W; Pestana JO
    Transplant Proc; 1992 Dec; 24(6):3072-3. PubMed ID: 1466060
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-TAC MOAB prolongs renal allografts in cynomolgus monkeys.
    Reed MH; Shapiro ME; Strom TB; Carpenter CB; Letvin NL; Reimann K; Weinberg DS; Waldmann TA; Kirkman RL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1028-30. PubMed ID: 2650064
    [No Abstract]   [Full Text] [Related]  

  • 13. Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients.
    Langley J; Dickerman R; Vergne-Marini P; Williams J; Jensik S; Kenyon N; Anderson J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):939-43. PubMed ID: 8442275
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 15. Propagation and characterization of lymphocytes infiltrating renal allografts.
    Bachetoni A; Cinti P; Poli L; Bruzzone P; Alfani D; Molajoni ER; Cortesini R
    Transplant Proc; 1993 Jun; 25(3):2317-9. PubMed ID: 8516914
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of cellular events within stable and rejecting allografts in cynomolgus monkeys.
    Wee SL; Colvin RB; Stroka DM; Jolliffe LK; Cosimi AB
    Transplant Proc; 1991 Feb; 23(1 Pt 1):821-3. PubMed ID: 1990702
    [No Abstract]   [Full Text] [Related]  

  • 17. Kidney transplantation: mechanisms of rejection and acceptance.
    Cornell LD; Smith RN; Colvin RB
    Annu Rev Pathol; 2008; 3():189-220. PubMed ID: 18039144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of IgG HLA antibodies in patients with long-surviving renal allografts.
    Norman PJ; Harmer AW; Koffman CG; Vaughan RW
    Transplant Proc; 1995 Feb; 27(1):999-1000. PubMed ID: 7879260
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine effect on immunoregulatory cells in kidney transplant recipients: suppression of gamma-interferon and interleukin production.
    Yoshimura N; Kahan BD; Matsui S; Kita M; Hamashima T; Oka T
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):69-74. PubMed ID: 3129846
    [No Abstract]   [Full Text] [Related]  

  • 20. Exhaustive differentiation of alloreactive CD8+ T cells: critical for determination of graft acceptance or rejection.
    Steger U; Denecke C; Sawitzki B; Karim M; Jones ND; Wood KJ
    Transplantation; 2008 May; 85(9):1339-47. PubMed ID: 18475193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.